title: AIDS research. FDA panel recommends anti-HIV drug for prevention.
authors.forename: Jon
authors.initials: J
authors.lastname: Cohen
mesh_terms: D026683:Advisory Committees; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017277:Drug Approval; D004338:Drug Combinations; D024882:Drug Resistance, Viral; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D005260:Female; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D008297:Male; D055118:Medication Adherence; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D012309:Risk-Taking; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019380:Anti-HIV Agents; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D009943:Organophosphorus Compounds; D003841:Deoxycytidine